Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00140049
Status:
COMPLETED
Last Update Posted:
2021-02-18
First Post:
2005-08-29
Brief Title:
A 12week Randomized Evaluator-Masked Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W Glaucoma
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ocular Hypertension |
| Glaucoma Open Angle |
Keywords: